These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7887824)

  • 1. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis.
    Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
    Artif Organs; 1994 Dec; 18(12):880-7. PubMed ID: 7887824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On complement net generation in fast hemodialysis: are high blood flow rates bioincompatible?
    Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH
    Am J Kidney Dis; 1995 Jun; 25(6):896-903. PubMed ID: 7771486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-microglobulin generation and removal in long slow and short fast hemodialysis.
    Skroeder NR; Jacobson SH; Holmquist B; Kjellstrand P; Kjellstrand CM
    Am J Kidney Dis; 1993 May; 21(5):519-26. PubMed ID: 8488820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual differences in biocompatibility responses to hemodialysis.
    Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH
    Int J Artif Organs; 1994 Oct; 17(10):521-30. PubMed ID: 7896425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis.
    Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
    ASAIO Trans; 1990; 36(3):M637-9. PubMed ID: 2252771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
    Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
    ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction.
    Depner TA; Greene T; Daugirdas JT; Cheung AK; Gotch FA; Leypoldt JK
    ASAIO J; 2004; 50(1):85-93. PubMed ID: 14763497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a New Single-Needle Single-Pump Dialysis System with Simultaneous Monitoring of Dialysis Dose.
    Bieser W; Welsch M; Jakob M; Meibaum J; Rodriguez DA; Wolff H; Marcelli D; Barth C
    Artif Organs; 2018 Aug; 42(8):814-823. PubMed ID: 29663430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with urea reduction ratio in acute renal failure.
    Liangos O; Rao M; Ruthazer R; Balakrishnan VS; Modi G; Pereira BJ; Jaber BL
    Artif Organs; 2004 Dec; 28(12):1076-81. PubMed ID: 15554935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
    Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
    Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations.
    Navarro JF; del Castillo N; Fernández JL; Macía ML; Méndez ML; Chahin J; García-Nieto V; Gallego E; Mora-Fernández C; García J
    Artif Organs; 1997 Feb; 21(2):91-5. PubMed ID: 9028489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the length of each hemodialysis session by on-line dialysate urea monitoring.
    Hernandez-Herrera G; Martin-Malo A; Rodriguez M; Aljama P
    Nephron; 2001 Sep; 89(1):37-42. PubMed ID: 11528230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.